Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1394
https://www.valueinhealthjournal.com/article/S1098-3015(16)32760-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1316
First Page :
A589
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32760-7&doi=10.1016/j.jval.2016.09.1394